Approval for the addition of the antibiotic erythromycin at concentrations of 0.12, 0.25 and 0.5 micrograms/ml to the vitek(r) 2 s. pneumoniae susceptibility test system.  The device, as mofified, will be marketed under the trade name vitek(r) 2 s. pneumoniae susceptibility test cards for use in the vitek(r) 2 system and is indicated for use for the susceptibility testing of streptococcus pneumoniae to erythromycin in the range of <=0.06 to >=1 micrograms/ml.